UK research-peptide reference
Research peptides — UK education hub
“Research peptides” is a marketing label, not a UK regulatory category. Most compounds sold this way are not licensed UK medicines and have weak human evidence. This hub orients you to what the label actually means, the regulatory framework, the common compounds, and the safer educational alternatives.
Start here
Research peptides and UK law
Plain-English UK regulatory framing for unlicensed compounds.
'Not for human consumption' claims
What that label does and doesn't mean under UK law.
Unlicensed peptide risks (Safety Centre)
Documented safety issues with unregulated supply.
No dosing, no sourcing policy
Why we don't publish doses, recipes, or supplier ranks.
Most-marketed unlicensed peptides
BPC-157
Pentadecapeptide marketed for tissue healing; no human RCT data.
TB-500
Thymosin beta-4 fragment marketed for recovery; WADA S2.
MOTS-c
Mitochondrial-derived peptide marketed for longevity; no Phase 3.
Epitalon
Pineal tetrapeptide marketed for longevity; Russian-source evidence.
Selank / Semax
Russian-developed nootropics; Western evidence limited.
GHK-Cu
Cosmetic peptide; injectable use unsupported.